72.11.Z - Research and experimental development on biotechnology
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
26.51.Z - Manufacture of instruments and appliances for measuring, testing and navigation
26.60.Z - Manufacture of irradiation, electromedical and electrotherapeutic equipment
32.50.Z - Manufacture of medical and dental instruments and supplies
46.46.Z - Wholesale of pharmaceutical goods
47.73.Z - Dispensing chemist in specialised stores
72.19.Z - Other research and experimental development on natural sciences and engineering
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 234,1 | 108,9 | 490,7 | 350,7 |
Gross profit (loss) | 33,2 | -22,2 | 376,7 | 1798 |
Net profit (loss) | 30,2 | -22,2 | 344,7 | 1654 |
Liabilities and provisions for liabilities | 103,9 | 0,9 | 38 | 4235,6 |
Income tax | 3 | 0 | 31,9 | -∞ |
Working assets | 234,1 | 94,9 | 483,7 | 409,8 |
Equity capital | 130,2 | 108 | 452,7 | 319,1 |
Basic operational activity income | 78,3 | 61 | 921 | 1409,9 |
% | % | % | p.p. | |
Profitability of capital | 23,2 | -20,5 | 76,1 | 96,6 |
Equity capital to total assets | 55,6 | 99,2 | 92,3 | -6,9 |
Gross profit margin | 42,4 | -36,4 | 40,9 | 77,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane